Oppenheimer & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.7M | Sell |
259,210
-23,835
| -8% | -$3.14M | 0.35% | 51 |
|
|
2026
Q1 | $39.4M | Buy |
283,045
+14,941
| +6% | +$2.09M | 0.48% | 36 |
|
|
2025
Q4 | $32.9M | Sell |
268,104
-25,216
| -9% | -$3.06M | 0.47% | 32 |
|
|
2025
Q3 | $32.6M | Sell |
293,320
-4,137
| -1% | -$470K | 0.4% | 34 |
|
|
2025
Q2 | $33M | Buy |
297,457
+7,231
| +2% | +$770K | 0.44% | 31 |
|
|
2025
Q1 | $32.5M | Buy |
290,226
+3,883
| +1% | +$401K | 0.49% | 29 |
|
|
2024
Q4 | $26.4M | Buy |
286,343
+1,835
| +0.6% | +$165K | 0.39% | 38 |
|
|
2024
Q3 | $23.9M | Sell |
284,508
-3,964
| -1% | -$302K | 0.36% | 46 |
|
|
2024
Q2 | $19.8M | Sell |
288,472
-7,259
| -2% | -$484K | 0.31% | 60 |
|
|
2024
Q1 | $21.7M | Sell |
295,731
-3,299
| -1% | -$254K | 0.36% | 52 |
|
|
2023
Q4 | $24.2M | Sell |
299,030
-33,399
| -10% | -$2.6M | 0.45% | 32 |
|
|
2023
Q3 | $24.9M | Sell |
332,429
-8,124
| -2% | -$625K | 0.51% | 28 |
|
|
2023
Q2 | $26.2M | Sell |
340,553
-8,060
| -2% | -$643K | 0.53% | 26 |
|
|
2023
Q1 | $28.9M | Sell |
348,613
-2,707
| -0.8% | -$224K | 0.61% | 18 |
|
|
2022
Q4 | $30.2M | Sell |
351,320
-66,527
| -16% | -$5.27M | 0.69% | 18 |
|
|
2022
Q3 | $25.8M | Buy |
417,847
+24,461
| +6% | +$1.54M | 0.6% | 20 |
|
|
2022
Q2 | $24.3M | Sell |
393,386
-5,455
| -1% | -$338K | 0.52% | 27 |
|
|
2022
Q1 | $23.7M | Sell |
398,841
-30,819
| -7% | -$1.97M | 0.43% | 36 |
|
|
2021
Q4 | $31.2M | Sell |
429,660
-22,549
| -5% | -$1.55M | 0.55% | 20 |
|
|
2021
Q3 | $31.6M | Buy |
452,209
+34,814
| +8% | +$2.45M | 0.59% | 20 |
|
|
2021
Q2 | $28.7M | Buy |
417,395
+66,644
| +19% | +$4.45M | 0.52% | 23 |
|
|
2021
Q1 | $22.7M | Buy |
350,751
+11,440
| +3% | +$738K | 0.45% | 35 |
|
|
2020
Q4 | $19.8M | Sell |
339,311
-51,023
| -13% | -$3.08M | 0.42% | 46 |
|
|
2020
Q3 | $24.7M | Sell |
390,334
-7,567
| -2% | -$525K | 0.62% | 22 |
|
|
2020
Q2 | $30.6M | Sell |
397,901
-33,803
| -8% | -$2.59M | 0.79% | 16 |
|
|
2020
Q1 | $32.3M | Buy |
431,704
+51,611
| +14% | +$3.57M | 0.98% | 11 |
|
|
2019
Q4 | $24.7M | Sell |
380,093
-5,506
| -1% | -$359K | 0.61% | 29 |
|
|
2019
Q3 | $24.4M | Sell |
385,599
-9,444
| -2% | -$617K | 0.67% | 26 |
|
|
2019
Q2 | $26.7M | Sell |
395,043
-1,284
| -0.3% | -$84.5K | 0.73% | 20 |
|
|
2019
Q1 | $25.8M | Sell |
396,327
-15,485
| -4% | -$1.03M | 0.69% | 24 |
|
|
2018
Q4 | $25.8M | Sell |
411,812
-3,343
| -0.8% | -$234K | 0.81% | 18 |
|
|
2018
Q3 | $32.1M | Buy |
415,155
+1,984
| +0.5% | +$150K | 0.82% | 15 |
|
|
2018
Q2 | $29.3M | Sell |
413,171
-601,960
| -59% | -$42.5M | 0.79% | 14 |
|
|
2018
Q1 | $76.5M | Buy |
1,015,131
+13,153
| +1% | +$1.05M | 1.97% | 2 |
|
|
2017
Q4 | $71.8M | Sell |
1,001,978
-2,175
| -0.2% | -$165K | 1.85% | 2 |
|
|
2017
Q3 | $81.4M | Sell |
1,004,153
-21,297
| -2% | -$1.63M | 2.18% | 2 |
|
|
2017
Q2 | $72.6M | Buy |
1,025,450
+8,471
| +0.8% | +$564K | 2% | 2 |
|
|
2017
Q1 | $69.1M | Sell |
1,016,979
-45,697
| -4% | -$3.21M | 1.96% | 2 |
|
|
2016
Q4 | $76.1M | Sell |
1,062,676
-54,508
| -5% | -$4.05M | 2.22% | 1 |
|
|
2016
Q3 | $88.4M | Sell |
1,117,184
-54,898
| -5% | -$4.46M | 2.58% | 1 |
|
|
2016
Q2 | $97.8M | Sell |
1,172,082
-12,419
| -1% | -$1.1M | 2.91% | 1 |
|
|
2016
Q1 | $109M | Sell |
1,184,501
-9,478
| -0.8% | -$855K | 3.3% | 1 |
|
|
2015
Q4 | $121M | Buy |
1,193,979
+18,496
| +2% | +$1.92M | 3.59% | 1 |
|
|
2015
Q3 | $115M | Buy |
1,175,483
+143,338
| +14% | +$15.9M | 3.51% | 1 |
|
|
2015
Q2 | $121M | Buy |
1,032,145
+480,773
| +87% | +$52.5M | 3.36% | 1 |
|
|
2015
Q1 | $54.1M | Buy |
551,372
+8,253
| +2% | +$838K | 1.47% | 3 |
|
|
2014
Q4 | $51.2M | Sell |
543,119
-12,086
| -2% | -$1.25M | 1.47% | 3 |
|
|
2014
Q3 | $59.1M | Sell |
555,205
-15,981
| -3% | -$1.56M | 1.76% | 3 |
|
|
2014
Q2 | $47.4M | Buy |
571,186
+22,843
| +4% | +$1.78M | 1.42% | 3 |
|
|
2014
Q1 | $38.9M | Buy |
548,343
+12,038
| +2% | +$944K | 1.17% | 4 |
|
|
2013
Q4 | $40.3M | Buy |
536,305
+15,165
| +3% | +$1.06M | 1.29% | 4 |
|
|
2013
Q3 | $32.8M | Buy |
521,140
+36,913
| +8% | +$2.21M | 1.15% | 4 |
|
|
2013
Q2 | $24.8M | Buy |
+484,227
| New | +$25.2M | 0.96% | 6 |
|
Other funds holding GILD
Oppenheimer & Co's GILD Position: Q2 2026 in Review
Oppenheimer & Co reduced its Gilead Sciences (GILD) stake by 8.4% in Q2 2026, selling an estimated $3.14M and leaving 259,210 shares worth $32.7M. The position accounts for 0.35% of the portfolio, ranked #51.
Oppenheimer & Co first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $121M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Oppenheimer & Co held 259,210 shares of Gilead Sciences worth $32.7M as of Q2 2026.
- Oppenheimer & Co sold 23,835 Gilead Sciences shares in Q2 2026, an estimated $3.14M.
- Gilead Sciences made up 0.35% of Oppenheimer & Co's portfolio in Q2 2026, its #51 holding.
- Oppenheimer & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Oppenheimer & Co's Gilead Sciences position peaked at $121M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.